Zymofix, a Belgian industrial biotech startup specializing in the production of beneficial microorganisms through the fermentation of biomass residues, has successfully raised €2 million in funding. The investment round was led by High-Tech Gründerfonds (HTGF) and included contributions from The Nest Family Office and VP Capital.
Founded in 2022 by Emile Redant, Zymofix aims to revolutionize microorganism production, utilizing biomass residues such as agricultural waste to cultivate beneficial microbes. These microorganisms are designed to improve soil health, enhance agricultural productivity, and mitigate environmental impact. Through a novel solid-state fermentation process, Zymofix converts waste materials into high-value microbial solutions.
The new funding will enable Zymofix to enhance its fermentation platform and expedite the commercialization of its products in collaboration with corporate partners. The company plans to expand its workforce, with the addition of four new employees in the fields of research and development (R&D) and project management anticipated within the next quarter.
The approach taken by Zymofix focuses on leveraging low-cost, locally sourced biomass to lower manufacturing expenses, making their microbial solutions economically viable for use in row crops such as maize, wheat, and sugar beet. The technology’s scalability and adaptability are highlighted as key factors that enable tailored solutions across various sectors including agriculture, waste treatment, and industrial bioremediation.
Emile Redant, CEO of Zymofix, stated, “Our mission is to scale the production of beneficial microorganisms, transforming waste into valuable resources that foster ecosystem regeneration. This investment will enable us to bring our high-quality, scalable biosolutions to market faster, driving positive impact on planetary health.”
